Results 131 to 140 of about 85,245 (197)
Innovations in autologous transplantation for hematologic malignancy
openaire +3 more sources
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley +1 more source
Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis. [PDF]
Noui Y+9 more
europepmc +1 more source
The international prognostic index (IPI)‐driven trial inclusion criteria may have contributed to the failure of some of the first‐line trials in large B‐cell lymphoma (LBCL). GLA and LYSA collaborated to improve prognostic stratification in LBCL by analyzing data from trial cohorts and proposed the smIPI.
Umut Yılmaz+24 more
wiley +1 more source
Autologous muscle precursor cell injection into the bladder neck improves the symptoms of stress urinary incontinence in adult females. [PDF]
Dutta R+7 more
europepmc +1 more source
Summary Understanding bloodstream infection (BSI) epidemiology is crucial for optimizing antibiotic therapy in paediatric haematology–oncology patients undergoing chemotherapy or haematopoietic cell transplantation (HCT). However, updated paediatric data remain scarce.
Francesco Baccelli+35 more
wiley +1 more source
To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients. [PDF]
Sharma A, John T.
europepmc +1 more source
Summary In allogeneic haematopoietic stem cell transplantation (HSCT), important clinical decisions depend upon assessment of chimerism, including immunosuppressant dosing and donor lymphocyte infusions (DLI), which in turn can have major impacts on disease control, graft‐versus‐host disease (GVHD), immunity and ultimately patient survival.
Andrew Clark+12 more
wiley +1 more source
Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of Korea. [PDF]
Baek DW+8 more
europepmc +1 more source